Hackensack Meridian Health Oncology
Hackensack University Medical Center Clinical Research on mRNA Vaccine Intervention Benefits in High-Risk Melanoma
John Theurer Cancer Center (JTCC) physician co-authors promising findings on safety and efficacy of mRNA skin cancer vaccination used with current immunotherapy treatments
Hackensack Meridian Health Among First Hospitals to Provide BgRT Treatment Opening a New Option for Stage IV Cancer
John Theurer Cancer Center 6th Site in the World to Adopt RefleXion®X1 Precision Radiation Treatment
Genetic Tie to Cancer and Treatment-Related Cognitive Decline for Older Breast Cancer Survivors
Hackensack University Medical Center participates in study identifying two SNPs with potential cognition impact
Researchers at John Theurer Cancer Center at Hackensack University Medical Center Help Develop New Liquid Biopsy Technique
Approach combines cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumors
ZUMA-1 Five-Year Follow-Up Shows Axicabtagene Ciloleucel Treatment Success for Refractory Large B-Cell Lymphoma
John Theurer Cancer Center at Hackensack University Medical Center researchers assess outcomes for aggressive B-cell lymphoma treatment
John Theurer Cancer Center at Hackensack University Medical Center Study Tracks Long-Term Survival With First-Line Nivolumab Plus Ipilimumab in Patients With Advanced Non-Small-Cell Lung Cancer
Pooled analysis deepens clinical benefit knowledge and assesses survival impact
Improved Survival for B-NHL With Fludarabine Exposure Target Window Identified in John Theurer Cancer Center at Hackensack University Medical Center Research
Negative effects of Flu over and underexposure found common with body-surface areas based dosing in study presented at ASH annual meeting